0001209191-21-027683.txt : 20210420
0001209191-21-027683.hdr.sgml : 20210420
20210420195400
ACCESSION NUMBER: 0001209191-21-027683
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210420
FILED AS OF DATE: 20210420
DATE AS OF CHANGE: 20210420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KENYON LAWRENCE A
CENTRAL INDEX KEY: 0001230484
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37759
FILM NUMBER: 21839201
MAIL ADDRESS:
STREET 1: C/O OUTLOOK THERAPEUTICS, INC.
STREET 2: 7 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outlook Therapeutics, Inc.
CENTRAL INDEX KEY: 0001649989
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 383982704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 4260 U.S. ROUTE 1
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
BUSINESS PHONE: 6096193990
MAIL ADDRESS:
STREET 1: 4260 U.S. ROUTE 1
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
FORMER COMPANY:
FORMER CONFORMED NAME: Oncobiologics, Inc.
DATE OF NAME CHANGE: 20150804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-20
0
0001649989
Outlook Therapeutics, Inc.
OTLK
0001230484
KENYON LAWRENCE A
C/O OUTLOOK THERAPEUTICS, INC.
4260 US ROUTE 1
MONMOUTH JUNCTION
NJ
08852
1
1
0
0
CEO, Pres, CFO, Treas & Secy
Common Stock
2021-04-20
4
P
0
10000
1.83
A
18926
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within a $1.00 range. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
/s/ Lawrence Kenyon
2021-04-20